CHAPPER healthcare is delighted to be attending and exhibiting at the World Orphan Drug Congress USA, being held in Washington this month.
Taking place at the Gaylord National Harbour Hotel between at 25 – 27th April 2018, the exhibition focusses on the most pressing challenges and opportunities to bring rare disease therapies to patients faster.
The World Orphan Drug Congress USA has evolved from a one-track conference focused on regulatory pathways, policy and incentives, to a global gathering of 1,000 leaders in orphan drugs from 38 countries, and over 135 presentations covering all aspects of orphan drug development and rare disease research.
Orphan drugs are treatments for rare diseases of which there are 7,000 different types. 50% of patients are children of whom 35% will sadly die before their first birthday.
“We are very excited to be attending the World Orphan Drug Congress as it’s a great platform to discuss the challenges and developments in the treatment of rare diseases” said Jonathan Chapper, CEO.
“We are dedicated to helping manufacturers improve the health of patients around the world and ensuring that all patients have access to the medicines they so desperately need.”
For over 40 years, CHAPPER healthcare has been improving patients’ access to medicines by successfully supplying pharmaceuticals, including orphan drugs, non-registered medicines and emergency medicines to clients across the world. To arrange an appointment with the team please contact your account representative or email email@example.com